HOXA1 Is an Antagonist of ERα in Breast Cancer

Breast cancer is a heterogeneous disease and the leading cause of female cancer mortality worldwide. About 70% of breast cancers express ERα. HOX proteins are master regulators of embryo development which have emerged as being important players in oncogenesis. HOXA1 is one of them. Here, we present...

Descripción completa

Detalles Bibliográficos
Autores principales: Belpaire, Magali, Ewbank, Bruno, Taminiau, Arnaud, Bridoux, Laure, Deneyer, Noémie, Marchese, Damien, Lima-Mendez, Gipsi, Baurain, Jean-François, Geerts, Dirk, Rezsohazy, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417444/
https://www.ncbi.nlm.nih.gov/pubmed/34490074
http://dx.doi.org/10.3389/fonc.2021.609521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417444/
https://www.ncbi.nlm.nih.gov/pubmed/34490074
http://dx.doi.org/10.3389/fonc.2021.609521

Ejemplares similares